Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.
This report, with focus on top players in the global and Japan, studies the Synthetic Biology market's development status and future trend in the global and Japan. It splits Synthetic Biology market by type and by applications to fully and deeply research and reveal market profile and prospect.
The major players include
Amyris, Inc. (U.S.)
GenScript USA Inc. (U.S.)
Intrexon Corporation (U.S.)
Integrated DNA Technologies (IDT) (U.S.)
New England Biolabs, Inc. (NEB) (U.S.)
Royal DSM (Netherlands)
Synthetic Genomics, Inc (California)
Thermo Fisher Scientific, Inc. (U.S.)
Geographically, this report splits the Global market into the following regions:
Middle East & Africa
On the basis of product, the Synthetic Biology market is primarily split into
Xeno-nucleic Acids (XNA)
Cloning and Assembly kits